Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AQUAVAN for sedation in colonoscopy
NCT00261599Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2006
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fospropofol disodium (3 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Sedation Success. Started Mar 2006; status: completed.
02
Drugs
fospropofol disodium
Beyond the preview
Go deeper on NCT00261599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00261599.